Szanowni Państwo, informujemy, że w puli organizatorów pozostały jeszcze wolne pokoje hotelowe.
Zainteresowanych prosimy o kontakt pod adresem ptk2015@casusMEDICAL.pl
Dear Sirs, Colleagues,
we are pleased that the XX Jubilee PCS Congress - the most important scientific and educational meeting for cardiologists in Poland is held in Poznań again.
On behalf of the Organizing Committee it is our great pleasure to invite you to the capital of the Great Poland Region again to participate in the
XX International Congress of the Polish Cardiac Society,
which takes place on September 15-17, 2016
For the twentieth time, we are going to face challenges of contemporary medicine and raise the most significant issues related to cardiology. We hope each participant will have an opportunity to review the latest scientific research, recommendations and diagnostic methods as well as achievements in cardiology, cardiac surgery and related fields.
The Jubilee constitutes an excellent opportunity to rethink and summarise the progress of the medical field in which we are proudly involved for the patients’ good.
Congresses of the Polish Cardiac Society are primarily characterized by reach scientific program, however, we are aware that the venue of the event is of great importance, as well. Therefore, we warmly invite you to the capital of the Great Poland Region.
Romuald Ochotny, Przemysław Mitkowski
The Chairman of the Organizing Committee of the XX International Congress of the Polish Cardiac Society
Komitet Naukowy
Dariusz Dudek (Kraków) – Przewodniczący KNK
Piotr Ponikowski (Wrocław) – Prezes-Elekt PTK
Jarosław Kaźmierczak (Szczecin) – Konsultant krajowy ds. kardiologii
Krzysztof J. Filipiak (Warszawa) – Redaktor Naczelny "Kardiologii Polskiej"
Andrzej Budaj (Warszawa) – Przewodniczący Komisji Wytycznych i Szkolenia
Skład członków tworzących grupy tematyczne:
Michał Krejca (Katowice)
Jacek Legutko (Kraków)
Radosław Parma (Katowice)
Beata Średniawa (Zabrze)
Andrzej Beręsewicz (Warszawa)
Małgorzata Kurpesa (Łódź)
Katarzyna Bieganowska (Warszawa)
Rafał Baranowski (Warszawa)
Przemysław Mitkowski (Poznań)
Grażyna Brzezińska-Rajszys (Warszawa)
Monika Komar (Kraków)
Jarosław D. Kasprzak (Łódź)
Piotr Lipiec (Łódź)
Magdalena Kostkiewicz (Kraków)
Mirosław Kowalski (Warszawa)
Ewa Jankowska (Wrocław)
Jadwiga Nessler (Kraków)
Marcin Kurzyna (Otwock)
Karol Kamiński (Białystok)
Ryszard Piotrowicz (Warszawa)
Grzegorz Kopeć (Kraków)
Tomasz Zdrojewski (Gdańsk)
Andrzej Januszewicz (Warszawa)
Izabela Uchmanowicz (Wrocław)
Dorota Krówczyńska (Warszawa)
Sekretarz KNK PTK: Zbigniew Siudak
Komitet organizacyjny
Romuald Ochotny
Przemysław Mitkowski
Thursday15September |
SALA 1 | SALA 2 | SALA 3 | SALA 4 | SALA 5 | SALA 6 | SALA 7 | SALA 8 | SALA 9 | SALA 10 | SALA 11 | SALA 12 | SALA 13 | SALA Sesje plakatowe |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 09:00 - 10:30 |
Heart failure in women – how to prevent, how to treat? Heart failure in women – how to prevent, how to treat?Session of the PCS Working Group on Women Heart DiseasesChairpersons: M. Klocek (Kraków) Heart failure with preserved ejection fraction – a new insight How to prevent the development of heart failure after a heart attack? Drug treatment of heart failure in women – how to improve prognosis? Implantable devices in heart failure – are also effective in women? |
Who should undergo minimally invasive surgery and for whom a conventional surgery is better option? Who should undergo minimally invasive surgery and for whom a conventional surgery is better option?Session of the PCS Working Group on Cardiac SurgeryChairpersons: M. Jemielity (Poznań) Coronary heart disease: for whom is CCABG, OPCAB, MIDCAB, TECAB? Mitral valve surgery: conventional vs. minimally invasive. Advantages and disadvantages Who should undergo atrial fibrillation ablation and left atrial appendage closure with minimally invasive method and for whom conventional method is better |
Invasive cardiology in the prevention and treatment of stroke Invasive cardiology in the prevention and treatment of strokeSession of the PCS Association of Cardiovascular InterventionsChairpersons: J. Legutko (Kraków) The latest achievements in prevention and treatment of cardiovascular stroke – neurologist perspective Asymptomatic and symptomatic patient with significant carotid artery stenosis – conservative treatment, endarterectomy or stent? Patient with patent foramen ovale – when do we need to close the defect? Patient with atrial fibrillation – when do we need to eliminate left atrial appendage? Stroke as a complication of the invasive cardiology procedure – is it possible to prevent it? Interventional treatment of the ischemic stroke – is it time to cross the next frontier? Panel discussion: invasive cardiologist's present and future role in multidisciplinary teams in the prevention and treatment of stroke |
Acute heart failure – crucial first 24 hours in Intensive Cardiac Care Unit Acute heart failure – crucial first 24 hours in Intensive Cardiac Care UnitSession of the PCS Working Group on Acute Cardiac Care and ResuscitationChairpersons: B. Średniawa (Zabrze) Pitfalls of laboratory diagnostics The role of echocardiography – look not only into the heart Indications and limitations of modern imaging techniques in acute cardiac care patients Invasive diagnostic procedures – when to use it |
Ventricular arrhythmia – important questions Ventricular arrhythmia – important questionsSession of the PCS Working Group on Noninvasive Electrocardiology and TelemedicineChairpersons: I. Cygankiewicz (Łódź) Are you sure it is ventricular? Differentiation of arrhythmias Does ventricular always mean dangerous? Is drug treatment of ventricular arrhythmias obsolete? YES! Is drug treatment of ventricular arrhythmias obsolete? NO! |
How to evaluate the global risk in cardiovascular diseases prevention? How to evaluate the global risk in cardiovascular diseases prevention?Session of the PCS Working Group on Prevention and EpidemiologyChairpersons: W. Drygas (Warszawa) New version of global risk estimation and SCORE for Polish population Ideal Cardiovascular Health: theoretical frame and practical aplication in WOBASZ Study Is the present method of global risk estimation and SCORE optimal for Poland? |
Valvular heart disease – what is new in 2016? Valvular heart disease – what is new in 2016?Session of the PCS Working Group on Congenial and Valvular Heart DiseaseChairpersons: M. Komar (Kraków) Aortic valve Mitral valve Tricuspid valve |
Rigth-sided heart failure in left ventricular heart diseases Rigth-sided heart failure in left ventricular heart diseasesSession of the PCS Working Group on Heart FailureChairpersons: E. Straburzyńska-Migaj (Poznań) Pathophysiology of the right ventricle and pulmonary circulation Evaluation of the right ventricle Right-sided heart failure as prognostic factor Management of right-sided heart failure – pharmacotherapy? mechanical support? |
Systemic right ventricle – what do we know? Systemic right ventricle – what do we know?Session of the PCS Working Group on Adult and Adolescent Congenital Heart DiseasesChairpersons: A. Klisiewicz (Warszawa) Embryologic development and anatomy of the right ventricle – different, but is it worse? The natural history of the systemic right ventricle – what do we really know? How to assess the function of systemic right ventricle? The systemic right ventricle failure – how to manage? |
Acute coronary syndromeSession of the PCS Working Group on Nursing and Medical TechniqueChairpersons: M. Wolszczak (Warszawa) How to diagnose? How to treat? How to live after? |
Controversies in the European Society of Cardiology guidelines. How they are procured by experts who prepare questions for state examination in Cardiology?The joint session of the Club 30 and the National Consultant in cardiologyChairpersons: J. Kaźmierczak (Szczecin) Antithrombotic treatment (double antiplatelet therapy and triple antithrombotic therapy) in the context of proper preparation for various invasive procedures Antithrombotic treatment in stroke – summary of cardiological and neurological guidelines When, in whom and what treatment for patients with ACS and heart failure When and whom left ventricle assist should be considered during ACS and cardiac shock – the differences in indications for IABP and left ventricle assist device Hypertension – different target values for different patients. Who will benefit from the ASA use in hypertension? Prevention of AKI – discrepancies in guidelines issued in the same year |
|||
| 10:45 - 12:15 |
The biggest challenges in cardiac rehabilitation in 2016. Different approaches, common goal The biggest challenges in cardiac rehabilitation in 2016. Different approaches, common goalSession of the PCS Working Group on Cardiac Rehabilitation and Exercise PhysiologyChairpersons: R. Piotrowicz (Warszawa) Rehabilitation after myocardial infarction – necessity and appropriate completion of treatment Rehabilitation after myocardial infarction – it is not enough! Patient education is equally important – Schools of the Heart High-risk cardiac surgery – today’s expectations of rehabilitation Rehabilitation after high-risk cardiac surgeries – necessity and a difficult challenge Patient with heart failure – hybrid cardiac rehabilitation, direction of the future Patient with heart failure – rehabilitation is not enough |
Controversies in the treatment of acute pulmonary embolism Controversies in the treatment of acute pulmonary embolismSession of the PCS Working Group on Pulmonary CirculationChairpersons: M. Ciurzyński (Warszawa) Do NOAC replace vitamin K antagonists in the treatment of venous thromboembolism? Bleeding in patients with acute pulmonary embolism treated with NOAC – a clinically serious problem |
General Assembly of the Members of PCS Association Group on Cardiovascular Interventions General Assembly of the Members of PCS Association Group on Cardiovascular Interventions |
Problems of sport cardiology – sport, law, medicine Problems of sport cardiology – sport, law, medicineSession of the PCS Working Group on Sports CardiologyChairpersons: H. Krysztofiak (Warszawa) Doping in sport – definitions, resources, methods, procedures Cardiological complications resulting from using doping in sport Cardiological screening of young athletes Certification in sport medicine – legal aspects and dilemmas |
Modern cardiovascular imaging in cardiology practice Modern cardiovascular imaging in cardiology practiceSession of the PCS Working Group on Cardiac Magnetic Resonance Imaging and Computed TomographyChairpersons: M. Kruk (Warszawa) Cardiac computed tomography – translating research into clinical practice Cardiac MR imaging – current status and future directions Fusion, hybrid, and multimodality imaging in cardiovascular diagnostics and interventions |
New horizons in cardioprotection – whether or not and what to use aside from essential medications? New horizons in cardioprotection – whether or not and what to use aside from essential medications?Session of the PCS Working Group on Cardiovascular PharmacotherapyChairpersons: A. Mamcarz (Warszawa) Carnitine Coenzyme Q10 Ranolazine Vitamin D Trimetazidine |
Silent atrial fibrillation – silent killer. Section of Heart Rhythm of the Polish Cardiac Society initiative „Take the pulse and prevent a stroke”Session of the PCS Working Group on Heart RhythmChairpersons: J. Kaźmierczak (Szczecin) Silent atrial fibrillation – epidemiology and threats By all means... Diagnostics for silent atrial fibrillation Pharmacological and non-pharmacological silent atrial fibrillation treatment Can expensive methods turn out to be the cheapest? Selected insights of pharmacoeconomics into silent atrial fibrillation management |
Echocardiographic examination of an adult patient with congenital heart disease Echocardiographic examination of an adult patient with congenital heart diseaseSession of the PCS Working Group on EchocardiographyChairpersons: P. Lipiec (Łódź) Protocol of echocardiographic examination of an adult patient with congenital heart disease Congenital defects of LVOT, aortic valve and aorta Ventricular and atrial septal defect. Patent ductus arteriosus Tetralogy of Fallot. Ebstein’s anomaly Transposition of great arteries. The Fontan circulation |
Transcatheter closure of ventricular septal defects – old problems, new possibilities Transcatheter closure of ventricular septal defects – old problems, new possibilitiesSession of the PCS Working Group on Pediatric CardiologyExpert: R. Przybylski (Zabrze) New possibilities in transcatheter closure of congenital, perimembranous VSD Transcatheter closure of Gerbode VSD – multicenter study Transcatheter closure of postinfarction VSD Transcather VSD closure with PFM coils – multicenter study Hybrid, periventricular closure of muscular VSD |
Cardiac infarction and stroke – two faces of the same disease! Cardiac infarction and stroke – two faces of the same disease!Session of the PCS Working Group on Experimental CardiologyChairpersons: M. Kurpisz (Poznań) Introduction to the system of haemostasis Cryptogenic strokes – crosstalk with the heart Ischaemic stroke in a patient with the history of cardiac infarction – from pathophisiology to the therapy Cardiac infarction – crosstalk with the brain Cardiac infarction – new forms of antiplatelet and antithrombotic therapy |
Nuclear cardiology in special populations Nuclear cardiology in special populationsSession of the PCS Working Group on Nuclear CardiologyChairpersons: M. Kostkiewicz (Kraków) Nuclear imaging in patients with infective endocarditis Nuclear cardiology in women with suspected coronary artery disease Nuclear imaging in patients with hypertension Imaging in patients after coronary revascularization |
|||
| 12:30 - 14:00 |
Modern cardiological pharmacotherapy – when, with whom and why? Modern cardiological pharmacotherapy – when, with whom and why?Satellite session organized by BiofarmChairpersons: A. Tykarski (Poznań) Lacidipine Nebiwolol Torasemide |
Evolocumab – new perspectives in the treatment of lipid disorders Evolocumab – new perspectives in the treatment of lipid disordersSatellite session organized by AMGENChairpersons: P. Ponikowski (Wrocław) The landscape of hypercholesterolemia in the face of new ESC guidelines The role of PCSK9 inhibitors in the treatment of hypercholesterolemia – Evolocumab Patients who don't achieve recommended LDL-C targets. May Evolocumab solve the problem? – case study |
Cardiac contractility modulation (CCM) – nonexcitatory electrical stimulation of the heart in the therapy of chronic heart failureSatellite session organized by IMPULSE-DYNAMICSChairpersons: P. Ptaszyński (Łódź) CCM – pathophysiological background and clinical results of the therapy Therapy of chronic heart failure with CCM in own experience Therapy of chronic heart failure with CCM in own experience Discussion |
Session of original articles nominated for the prize of the PCS Scientific Committee – basic sciencesJury: A. Beręsewicz (Warszawa) Interactions of antazoline with human ether-à-go-go-related gene channels Diagnostic value of free circulating microRNAs' panel (miR1, miR-133a, miR-208a, miR-499) in differentiation of clinical types of coronary disease: acute myocardial infarction without ST segment elevation, unstable angina and stable coronary artery disease The variability of the atrioventricular conduction has asymmetrical features The effect of high-fat meal on the barrier functions and inflammatory status of human vascular endothelial cells Comparison of endomyocardial biopsy results between early and late dilated cardiomyopathy |
Session of original articles nominated for the prize of the PCS Scientific Committee – clinical sciencesJury: W. Wojakowski (Katowice) Transcatheter closure of paravalvular leaks using a Paravalvular Leak Device (PLD) – a prospective Polish registry Trends in prevention after a myocardial infarction in patients with reduced left ventricle ejection fraction in Poland Improvement of mitral regurgitation predicts response to cardiac resynchronization therapy Changing of the balloon pulmonary angioplasty strategy resulted in reduced complication ratio and mortality Temporal trends in treatment and outcomes of patients with NSTEMI and STEMI in Poland in years 2009–2013 – analysis of AMI-PL registry |
Session of original articles nominated for the prize of the PCS Scientific Committee – students' articlesJury: Z. Siudak (Kraków) Patterns of antithrombotic therapy in patients with atrial fibrillation in tertiary cardiology centre and general hospital in Belarus: still too far from the guidelines Prevalence of dietary supplements and over-the-counter drug use in patients with arterial hypertension Stress cardiomyopathy and coronary artery disease – contrary or complementary? A new look at the differential diagnosis of takotsubo syndrome Septal pouch – morphology and imaging methods Accuracy of electrocardiographic criteria for left ventricular hypertrophy in patients with aortic valve stenosis |
Students’ articles awarded at National Conferences for Students Students’ articles awarded at National Conferences for StudentsPrace studenckieJury: A. Dziewierz (Kraków) The article awarded at International Medical Congress of Silesia 2016 in Katowice: Accuracy of electrocardiographic criteria for left ventricular hypertrophy in patients with aortic stenosis The article awarded at XXX National Cardiology Conference for Students in Gdansk: The platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte ratio (NLR) – evaluation and comparison of prognostic indices in patients with heart failure The article awarded at 11th Bialystok International Medical Congress for Young Scientists in Bialystok: Similar clinical and echocardiographic outcomes of cardiac resynchronization therapy irrespectively to presence of left bundle branch block – insights from single-centre registry The article awarded at 54th Polish and 12th International Conference „Juvenes Pro Medicina” in Lodz: 10-year risk of atrial fibrillation in patients hospitalized in the Department of Cardiology The article awarded at 12th Warsaw International Medical Congress for Young Scientists in Warsaw: Evaluation of cardiac risk stratification tools in major vascular surgeries The article awarded at XI International Students' Conference on Cardiology in Zabrze: Early and long-term complications in more than one thousand recipients of implantable cardioverter-defibrillator or cardiac resynchronization therapy defibrillators – insights from Silesian Center for Heart Diseases Defibrillator Registry |
Poster session of articles nominated for the prize of the PCS Scientific Committee Poster session of articles nominated for the prize of the PCS Scientific CommitteeJury: M. Kurzyna (Otwock) ECG patterns are different in fibrosis positive and negative dilated cardiomyopathy patients Human aortic valve interstitial cells express coagulation factors: the impact of inflammatory stimulation The outcome of percutaneous procedures for symptomatic subclavian artery occlusive disease. The registry of the John Paul II Hospital in Krakow Lead-dependent venous occlusion; effectiveness of ipsilateral arteriovenous fistula for hemodialysis. Findings from 1633 preoperative venograms Remote monitoring improves long-term prognosis in heart failure patients with implantable cardioverter-defibrillators in real-life The left atrial appendage morphology correlates with stroke risk in patients with sinus rhythm Coronary artery computed tomography as the first-choice imaging diagnostics in patients with high probability of coronary artery disease – preliminary results of CAT-CAD study Novel prognostic value of combined echocardiography parameters compared to measurements acquired by right heart catheterization in patients with severe systolic heart failure within a year of observation The influence of air pollution on the occurrence and decompensation of cardiovascular diseases and mortality in the population of highly polluted agglomeration Early and 12-month mortality of young women and men with acute myocardial infarction – analysis from PL-ACS registry |
||||||
| 14:15 - 15:45 | Polish Forum of Science in Cardiac and Vascular Diseases | |||||||||||||
|
EORP – the way to know where we are EORP – the way to know where we areChairpersons: P. Hoffman (Warszawa) The EORP initiative An overview of the EU and Poland EORP findings: HF Long Term An overview of the EU and Poland EORP findings: AF Long Term An overview of the EU and Poland EORP findings: STEMI ACS An overview of the EU and Poland EORP findings: EUROASPIRE IV Future perspective General discussion |
Hybrid treatment strategies in heart diseases Hybrid treatment strategies in heart diseasesSession of national consultants (the Heart Team session)Chairpersons: G. Opolski (Warszawa) Hybrid treatment of multivessel coronary disease – in whom and how? – Cardiologist Hybrid treatment of multivessel coronary disease – in whom and how? – Cardiac Surgeon „Best of two worlds” in the hybrid treatment of arrhythmias – Cardiologist „Best of two worlds” in the hybrid treatment of arrhythmias – Cardiac Surgeon TAVI – valid option for high risk patients with symptomatic aortic stenosis – Cardiologist TAVI – valid option for high risk patients with symptomatic aortic stenosis – Cardiac Surgeon Role of Hybrid Approach using minimally invasive valve surgery and PCI in complex patients – Cardiologist Role of Hybrid Approach using minimally invasive valve surgery and PCI in complex patients – Cardiac Surgeon |
Polish Multi-Centre Clinical Trials and Centres: experience and practical conclusions Polish Multi-Centre Clinical Trials and Centres: experience and practical conclusionsChairpersons: E. Płońska-Gościniak (Szczecin) ONCOECHO – introduction: left chamber function assessment at rest ONCOECHO – cardiotoxicity of cancer medications in practice PolStresECHO – introduction: stress echo of the left chamber function PolStresECHO – what patient, what stress echo test in practice VIACRT – introduction: basics of qualifications to CRT VIACRT – the prognosis and the effect of CRT |
Lipid disorders from doctors’ of various specialisations point of view Lipid disorders from doctors’ of various specialisations point of viewChairpersons: J. Kaźmierczak (Szczecin) The problem appears in the childhood The influence of risk factors grows in the adulthood – general internal care Consequences in the form of ACS – cardiac care Specific situations – patients with familial hypercholesterolemia Elderly patients Discussion: are lipid centres necessary? |
Innovations in Polish cardiovascular medicine – will new technologies solve old problems? Innovations in Polish cardiovascular medicine – will new technologies solve old problems?Chairpersons: A. Witkowski (Warszawa) Remote monitoring of a cardiac patient – will it improve prognosis and reduce costs? Polish technological projects in cardiovascular medicine constitute an opportunity to raise economic competitiveness – biodegradable stents and polymers Polish technological projects in cardiovascular medicine constitute an opportunity to raise economic competitiveness – what is new in cardiac surgery? Translational and implementation research – it is high time to fill the gap Regenerative and cardioprotective therapies – the ups and downs Organizational innovations necessary to improve prognosis of patients with the history of myocardial infarction Revolution in interventional treatment of ischaemic stroke – the role of an Invasive Cardiologist |
Interventions in treatment of pulmonary circulation Interventions in treatment of pulmonary circulationChairpersons: A. Araszkiewicz (Poznań) Interventional pulmonary artery embolectomy in acute pulmonary embolism Surgical treatment of venous thromboembolism (VTE) Balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension Pulmonary artery denervation – new technique to treat pulmonary hypertension? |
New ESC/PCS guidelines – application in Polish conditions New ESC/PCS guidelines – application in Polish conditionsSession of the PCS Committee on Guidelines and EducationChairpersons: A. Fijałkowska (Warszawa) Diagnosis and treatment of pericardial diseases Diagnosis and treatment of pericardial diseases – commentary Management of acute coronary syndromes without persistent ST segment elevation Management of acute coronary syndromes without persistent ST segment elevation – commentary Diagnosis and treatment of pulmonary hypertension Diagnosis and treatment of pulmonary hypertension – commentary Management of patients with ventricular arrhythmias and the prevention of sudden cardiac death Management of patients with ventricular arrhythmias and the prevention of sudden cardiac death – commentary Prevention, diagnosis and treatment of infective endocarditis Prevention, diagnosis and treatment of infective endocarditis – commentary |
||||||||
| 16:00 - 17:30 |
Empagliflozin should be considered in patients with type 2 diabetes in order to prevent or delay the onset of HF and prolong life – ESC guidelinesSatellite session organized by Boehringer-IngelheimChairpersons: P. Ponikowski (Wrocław) New opportunities for cardiovascular protection in type 2 diabetes? Learnings from the EMPA-REG OUTCOME® trial ESC 2016 guidelines for the diagnosis and treatment of acute and chronic heart failure in patients with type 2 diabetes in the context of empagliflozin Empagliflozin – a breakthrough that will change clinical practice? |
What is the color of life… Come and decide by yourself... What is the color of life… Come and decide by yourself...Satellite session organized by ServierChairpersons: J. Stępińska (Warszawa) Introduction Different shades of the therapy – what leads me when making choices – the experts dialogue It’s not always colorful… How do I motivate my patients to persist in the therapy? The 20th century was the age of wisdom. The 21st century is ruled by heart and emotions. Discover the colors of your emotions Q & A session |
||||||||||||
| 17:45 - 19:15 |
Conference Opening Ceremony |
|||||||||||||
| 19:15 - 20:15 |
The accessibility of modern cardiology and innovations in Poland – the present and the future The accessibility of modern cardiology and innovations in Poland – the present and the futureSession of the Ministry of Health, the President of PCS, the National Consultant in Cardiology and the Chairperson of the Congress Programme Committee PCSChairpersons: P. Hoffman (Warszawa) The list of paradoxes related to cardiology and cardiac surgery in the healthcare organization The condition of cardiology in Poland and the prospects for evaluating and financing of medical services in 2017 Scientific research and innovations in Polish cardiology – how to ensure progress |
|||||||||||||
| 20:30 | GET TOGETHER | |||||||||||||
Friday16September |
SALA 1 | SALA 2 | SALA 3 | SALA 4 | SALA 5 | SALA 6 | SALA 7 | SALA 8 | SALA 9 | SALA 10 | SALA 11 | SALA 12 | SALA 13 | SALA Sesje plakatowe |
| 09:00 - 10:30 |
Cardiac patient – just cardiac? Nursing care aspects Cardiac patient – just cardiac? Nursing care aspectsChairpersons: D. Krówczyńska (Warszawa) Patient with acute kidney failure Patient with diabetes and metabolic syndrome Patient with neurologic complications Cancer patient Patient with hemorrhagic complications Elderly patient |
New challenges of cardiology. Who should be rehabilitated? New challenges of cardiology. Who should be rehabilitated?Chairpersons: D. Szalewska (Gdańsk) Should patients with CRT be rehabilitated? Adult patient with a congenital disorder. The role of rehabilitation Should patients with pulmonary arterial hypertension (PAH) be rehabilitated? |
Congestion in heart failure: overload or redistribution? Congestion in heart failure: overload or redistribution?Chairpersons: E. Straburzyńska-Migaj (Poznań) Pathophysiology and assessment of congestion How to treat congestion and what to achieve in acute phase? How to prevent the recurrence of congestion? |
The heart in hypertensionChairpersons: Z. Gąsior (Katowice) Evaluation of left ventricular hypertrophy on ECG – new indices, are they better? Echocardiographic evaluation in hypertensive patient – in every patient? Effect of antihypertensive treatment on the regression of left ventricular hypertrophy – are there differences between drugs? The heart in primary and secondary hypertension – are there differences? |
Three dimensions of contemporary cardiology of cardiac defects Three dimensions of contemporary cardiology of cardiac defectsChairpersons: P. Hoffman (Warszawa) Difficult anatomy and even more difficult surgical decisions. Two dimensions supported by imagination or spatial imaging? Three dimensional echocardiography. Attractive gadget or present-day instrument? Rotation, fusion, navigation – new words in interventionist's vocabulary Planning with the heart in the hand – how 3D model supports the treatment of congenital cardiac malformations |
„Tomorrow is today, but tomorrow” – progress in electrotherapy „Tomorrow is today, but tomorrow” – progress in electrotherapyChairpersons: M. Kurpesa (Łódź) Subcutaneous implantable cardioverter-defibrillator. Current position in prevention of sudden cardiac death. First Polish experiences Vagal nerve stimulator. An autonomic modulation in heart failure treatment Cardiac contractility modulation. A new option for heart failure patients Leadless cardiac pacemaker. Further miniaturization of implantable cardiac devices – totally intracardiac stimulator Lifevest – sudden cardiac death protection as a bridging to implantable cardioverter-defibrillator |
Revascularization in patients with non-ST elevation acute coronary syndromes (NSTE-ACS) Revascularization in patients with non-ST elevation acute coronary syndromes (NSTE-ACS)Chairpersons: R. Gil (Warszawa) Risk assessment and decision making: revascularization or conservative treatment Platelet inhibition and anticoagulation Percutaneous coronary intervention: indications and results Who is a candidate for surgical revascularization in the settings of NSTE-ACS? Long-term management in NSTE-ACS patients after revascularization |
Today's look at the diagnosis and treatment of aortic stenosis – new hope for patients at high risk Today's look at the diagnosis and treatment of aortic stenosis – new hope for patients at high riskSession recommended by the Scientific Committee for PCS CongressesChairpersons: M. Zembala (Zabrze) Diagnosis and qualification for the surgery of patients with aortic stenosis based on the latest AHA/ACC/ESC guidelines – is everything clear? Methods and results of conventional cardiac surgery in symptomatic aortic stenosis – whether cardiac surgery has said its last word? Transcatheter aortic valve implantation (TAVI) – highs and lows in 2016 New types of TAVI systems – hope for better results |
Patient with suspected or diagnosed coronary disease. What imaging technique to use – anatomic, functional or both?Chairpersons: M. Demkow (Warszawa) I definitely choose functional methods Coronary artery computed tomography as the first-choice imaging diagnostics in patients with high probability of coronary artery disease – preliminary results of CAT-CAD study My choice – anatomical methods Hybrid imaging – it is the real future |
Extreme effort and air pollution – do Poles know how to prevent a myocardial infarction? Extreme effort and air pollution – do Poles know how to prevent a myocardial infarction?Chairpersons: R. Topór-Mądry (Kraków) Cardiovascular health knowledge of adult Polish and its determinants.The results of two National Multicenter Health Surveys WOBASZ and WOBASZ II Temporal trends in early and long-term (up to 5 years) mortality in all patients hospitalized in years 2009–2013 due to acute myocardial infarction in Poland – from nationwide population AMI-PL study Physical exercise in extreme heights and cardiovascular system. Is the cardiological screening important? Transient and rapid increase in the levels of cardiovascular stress biomarkers in amateur middle-aged male after marathon run Summary – future prospects in epidemiology of cardiovascular diseases in Poland |
Implantable device – from diagnostics to an optimal therapy Implantable device – from diagnostics to an optimal therapyChairpersons: M. Sterliński (Warszawa) The impact of remote monitoring of patients with implanted cardioverter-defibrillator (ICD) and cardiac resynchronization therapy device (CRT-D) on healthcare costs in long-term follow-up The incidence of silent atrial fibrillation in patients with pacemaker Could one-year effect of cardiac resynchronization therapy on hemodynamic parameters evaluated by impedance cardiography be predicted The incidence and clinical significance of de novo depression after shock delivery in cardiac resynchronization therapy recipients Summary – home-monitoring in 2016 |
Case studyChairpersons: B. Jankowska-Polańska (Wrocław) Arteriovenous ECMO as a method supporting acute cardiopulmonary failure after coronary Artery Bypass Graft (CABG) – case study Tasks and competences of a nurse in care for a pediatric patient with high risk of sudden cardiac death (SCD) based on the case study of a patient with Brugada syndrome Different clinical course of reflex syncope in women |
Studies which have influenced contemporary cardiology. Dreams… and what next? Studies which have influenced contemporary cardiology. Dreams… and what next?Chairpersons: E. Płońska-Gościniak (Szczecin) Facts and myths about preventive cardiology Invasive evaluation of coronary flow reserve (CFR): standards and the cardiology market The future of minimally invasive imaging examinations – the necessity of different than ultrasound methods in everyday clinical practice Invasive treatment of atrial fibrillation: the cost/the effect in long-term observation Echocardiography in qualification for electrotherapy and the diagnosis of its complications The female heart |
AblationModerator: Ł. Szumowski (Warszawa) Efficacy and safety of zero-fluoroscopy ablation for idiopathic ventricular arrhythmias The impact of Ensite utilization in pediatric arrhythmia ablation on safety, procedure duration and number of RF lesions. Is it time to change the approach? Atrial fibrillation burden after cryoballoon ablation using subcutaneous injectable loop recorder (LINQ) assessment Fluoroscopy integrated with 3D mapping system. A new method of further reduction of fluoroscopy during ablation of atrial fibrillation Global atrial longitudinal strain is a powerful predictor of catheter ablation efficacy in patients with atrial fibrillation Silent cerebral embolism after left-sided accessory pathway ablation in Wolff-Parkinson-White syndrome The safety and feasibility of conscious sedation during cryoballoon pulmonary vein isolation for paroxysmal atrial fibrillation Non-fluoroscopic catheter ablation of ventricular arrhythmias – a single center experience Invasive cardiologyModerator: K. Milewski (Katowice) Does the effectiveness of recanalization of chronic occlusion depend on the location of obstruction? Balloon valvuloplasty – still vital tool in TAVI era Impact of coronary artery disease burden on 12-month mortality of patients after transcatheter aortic valve implantation Comparison of predictors, early and long-term outcomes of transradial versus transfemoral access site used for coronary angiography in real-life population – insights from Prospective Registry of Stable Angina management and treatment (PRESAGE registry) Clinical outcome, long-term survival and prognostic factors of cardiovascular events in patients treated with percutaneous angioplasty for renal artery stenosis Impact of pre-procedural coronary artery disease assessed by SYNTAX score on transcatheter aortic valve implantation outcome Outcomes and clinical predictors of mortality of patients treated with rotational atherectomy: a single center registry Transcatheter paravalvular leak closure and hemolysis – prospective registry Hybrid or staged carotid artery stenting and cardiac surgery as the treatment strategy for patients with severe, concurrent carotid and cardiac disease How long does it take? The learning curve in the field of the percutaneous treatment of coronary chronic total occlusion – single centre experience Acute and chronic pulmonary circulatory disorders Acute and chronic pulmonary circulatory disordersModerator: M. Ciurzyński (Warszawa) Atrial fibrillation in patients with acute pulmonary embolism: an enemy or a bystander Age-adjusted D-Dimer cut-off values in suspected acute pulmonary embolism to avoid unnecessary contrast enhanced examinations Early changes in arterial blood saturation as a marker of balloon pulmonary angioplasty effectiveness Reduction of major bleeding complication in patients hospitalized due to acute pulmonary embolism in reference cardiology center after implementation of the 2008 ESC guidelines into clinical practice High-density lipoprotein cholesterol level as a predictor of vasoreactivity in patients with idiopathic pulmonary arterial hypertension Increased systemic arterial stiffness in patients with chronic thromboembolic pulmonary hypertension Long-term outcomes for patients with pulmonary arterial hypertension treated with specific drug therapy in 2007–2016 P-selectin and sTWEAK content in platelets is diminished in patients with pulmonary arterial hypertension Preoperative echocardiography examination of right ventricle function in patients scheduled for LVAD implantation correlates with postoperative hemodynamic examinations Complications of electrotherapy Complications of electrotherapyModerator: A. Przybylski (Rzeszów) Radiotherapy can cause serious malfunction of modern implantable cardioverters-defibrillators (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) Risk factors of late infectious complications in patients with cardiac implantable electronic devices Early and long-term complications in more than one thousand recipients of implantable cardioverter-defibrillator or cardiac resynchronization therapy defibrillators – insights from the Silesian Center Defibrillator Registry Infectious complications in patients with cardiac resynchronisation therapy – risk factors and long-term prognosis Can anticoagulation play preventive role in lead related venous occlusion? Findings of 1573 preoperative venographies Risks related to extraction of lead having long dwell time. Experience obtained from 2036 transvenous lead extraction procedures Venous occlusion and stenosis in CIED carriers; chance of safe and effective utility of ipsilateral jugular venous approach for intensive therapy, anaesthesia and catheter haemodialysis. Analysis of 1633 venograms Transvenous lead extraction in children and young patients. Differences compared with adult patients The usefulness of CRP and white blood cell count in indentifying infectious complications of permament cardiac pacing Factors infuencing early and long-term prognosis after transvenous lead extraction procedures in patients with lead-dependent infective endocarditis The role of cardiac surgery in patients undergoing transvenous lead extraction. Experience from 2073 procedures in the high volume center Risk factors of major transvenous lead extraction complications; the role of abandoned lead extraction. Experience from 1915 procedures Prevention of cardiovascular diseases: advanced diagnostic techniques Prevention of cardiovascular diseases: advanced diagnostic techniquesModerator: B. Cybulska (Warszawa) CHA2DS2-Vasc score, as well as age and body mass index as the main risk factors of brain lesions in asymptomatic patients with paroxysmal non-valvular atrial fibrillation No impact of omega-3 PUFAs on platelet aggregation, thrombin generation and fibrin clot properties in patients with atherosclerosis and type 2 diabetes mellitus on optimal pharmacological therapy Efficacy and safety of lipoprotein apheresis by double cascade filtration and direct hemadsorption in severe heterozygous familial hypercholesterolemia Matrix Metalloproteinases 2 and 9, Tissue Inhibitors of Metalloproteinases 1 and 2 in plasma of patients with lower limb chronic ischemia and coexisting stable angina Insulin-like growth factor-binding protein 7 (IGFBP 7) as a new biomarker in coronary heart disease The correlation of HDL with biomarkers of inflammation in patients with early stages of coronary atherosclerosis |
| 11:00 - 12:30 |
Controversies in electrocardiology Controversies in electrocardiologyChairpersons: J. Kaźmierczak (Szczecin) I always precede implantation of ICD with VT-substrate ablation I perform cardiac ablation in each patient with asymptomatic features of ventricular pre-excitation pattern on ECG |
Imaging in hypertension and coexisting diseases Imaging in hypertension and coexisting diseasesSession recommended by Scientific Committee for PCS CongressesChairpersons: P. Hoffman (Warszawa) Heart (MRI, CT) Heart (echocardiography) Large vessels Carotid and renal arteries |
Early primary prevention of cardiovascular diseases Early primary prevention of cardiovascular diseasesChairpersons: A. Fijałkowska (Warszawa) Prevention of cardiovascular diseases and genetic conditions Prevention of obesity in children – role of nutrition The role of physical activity in children and youth Prevention strategies from prenatal phase to adulthood |
When ECG can be misinterpreted – or how not to cut corners analyzing electrocardiogram When ECG can be misinterpreted – or how not to cut corners analyzing electrocardiogramChairpersons: M. Kurpesa (Łódź) When I was surprised by ECG but not by a patient – what the heart can see? Abnormal ECG before and after interventions – what the heart remembers and what it reminds of? Seemingly normal and seemingly abnormal ECG in a patient with a pacemaker When an invasive cardiologist finds ECG confusing – does angiogram shows something different than ECG? |
Advances and controversies in the treatment of stable coronary artery disease Advances and controversies in the treatment of stable coronary artery diseaseChairpersons: M. Zembala (Zabrze) The primary treatment of stable coronary artery disease is optimal medical therapy The primary method of revascularization of patients with stable coronary artery disease and stenosis and/or multivessel disease is coronary artery bypass grafting |
Optimal management and innovative approaches for mechanical complications in acute myocardial infarctionChairpersons: J. Różański (Warszawa) Free wall rupture – immediate diagnosis is the key Acute mitral regurgitation – the possibilities of interventional cardiologist Acute mitral regurgitation – the domain of a cardiac surgeon Ventricular septal rupture – do we have an idea how to treat it effectively? |
The newest guidelines of ESC/PCS 2016 The newest guidelines of ESC/PCS 2016Session of the PCS Committee on Guidelines and EducationChairpersons: M. Tendera (Katowice) Management of acute and chronic heart failure Cardiovascular disease prevention in clinical practice Management of dyslipidemias Management of atrial fibrillation 2016 ESC Position Paper on Cancer Treatments and Cardiovascular Toxicity |
Infective endocarditis – what is new? Infective endocarditis – what is new?Session recommended by the Scientific Committee for PCS CongressesChairpersons: T. Hirnle (Białystok) The application of the ECHO test – what is new? CT – in whom? when could it be helpful? SPECT and PET – in whom? when could it be helpful? Who and when should be operated? Cardiac device-related infective endocarditis – what is new? |
Modern treatment of difficult patients in ICCU based on clinical cases Modern treatment of difficult patients in ICCU based on clinical casesChairpersons: B. Średniawa (Zabrze) Patient with advanced HF and RRT Patient with electrical storm and ECMO Unconscious patient with STEMI and MTH Patient with AF treated with NOAC requiring cardioversion and TEE |
ACS – the new experienceChairpersons: Z. Chmielak (Warszawa) The prognosis and invasive treatment of patients with NSTEMI depend on the electrocardiographic changes on admission to hospital – data from PL-ACS registry Benefits in bleeding rates and periprocedural mortality of radial approach in ST-segment elevation myocardial infarction. Propensity score analysis of data from ORPKI Polish National Registry Early and 1-year clinical outcomes of patients with heavily calcified coronary artery lesions presenting with acute coronary syndromes treated with rotational atherectomy Multivessel percutaneous coronary intervention versus coronary artery bypass grafting for patients with non-ST-segment elevation acute coronary syndromes in routine clinical practice Transcatheter closure of postinfarction ventricular septal defect – in-hospital outcome and follow-up analysis Summary – progress and controversies in interventional treatment of acute coronary syndromes |
Electrophysiology and electrotherapy – untypical problems of typical patients Electrophysiology and electrotherapy – untypical problems of typical patientsChairpersons: K. Kaczmarek (Łódź) Bipolar irrigated radiofrequency ablation of resistant ventricular tachycardia with a septal intramural origin: Should we implant a permanent pacemaker in patients with left bundle brunch block and PQ prolongation following transcatheter aortic valve implantation? Hybrid ablation supported by left ventricular assist device in patient with hemodynamic unstable ventricular tachycardia storm Asymptomatic pulmonary embolism after transvenous lead extraction due to lead-dependent infective endocarditis with large vegetations |
Challenges for a cardiologist in health care for a pregnant patient: cardiac tumor, cardiomyopathy, anticoagulationChairpersons: K. Mizia-Stec (Katowice) Anticoagulation is a challenge not only for the cardiologists Malignant tumor of the right atrium in a pregnant woman – first manifestation by paroxysmal atrial fibrillation Advanced hypertrophic cardiomyopathy diagnosed in early pregnancy – prevention of sudden cardiac death |
Imaging of big vessels in patients with congenital heart defects – what to choose? Imaging of big vessels in patients with congenital heart defects – what to choose?Chairpersons: O. Trojnarska (Poznań) I choose MRI, because... Precision and safety of interventions are my priority, so... I want to see, touch, simulate, since... I do computed tomography due to... |
Diagnostics and treatment of congestive heart failure Diagnostics and treatment of congestive heart failureModerator: J. Nessler (Kraków) Depression in Polish patients with heart failure – the prevalence and independent predictors. Results of a CAPS-LOCK-HF (Complex Assessment of Psychological Status Located in Heart Failure) study Assessment of thromboembolic risk and antithrombotic treatment in population of Polish patients with heart failure and atrial fibrillation in European Society of Cardiology Heart Failure Long-term Registry The journey of the heart failure patient based on single-centre data analysis The value of echocardiographic TEI index, E/E' ratio and BNP serum level in patients with heart failure with preserved ejection fraction Management of systolic heart failure in ambulatory care in Poland – data from the international QUALIFY survey Quality of life in patients with heart failure and sleep apnea. Results of the Hart Failure Quality of Life (HEAL-QoL) study Impact of concomitant type 2 diabetes mellitus and its treatment on long-term outcome in systolic heart failure patients The influence of metabolic syndrome on 1-year surveillance of patients with chronic heart failure without atrial fibrillation How elderly patients with chronic heart failure are treated in clinical practice? – the subanalysis of DATA-HELP registry Fractional urinary excretion of potassium – mortality and treatment pattern in heart failure Calculated colloid osmotic pressure as an independent risk factor of mortality in patients with chronic heart failure Experimental cardiologyModerator: A. Beręsewicz (Warszawa) The effects of dabigatran on prothrombin, factor VII and tissue factor expression in human aortic valve interstitial cells Transcriptional activity of nuclear factor kappa B (NF-κB) in patients with early stages of coronary artery disease and cardiovascular risk factors – preliminary observations The miRNA-21 levels are associated with serum lipids profile in early phase of non-ST elevation acute coronary syndromes MicroRNA’s expression in cerebral ischemia resulting from carotid artery stenosis – the immediate findings and long-term prognosis Antazoline – effective antiarrhythmic drug for acute termination of atrial fibrillation. Insights into drug-induced electrocardiographic and haemodynamic effects Peripheral chemoreceptors' blockade abolishes asphyxia-induced hypertension Inflammatory markers of the postpericardiotomy syndrome The omparison of unipolar and bipolar ablation on transmurality of the lesion New biomarkers in heart failure New biomarkers in heart failureModerator: M. Kasztura (Wrocław) Iron status in patients with heart failure with reduced ejection fraction with ischaemic versus non-ischaemic aetiology An assessment of the frequency of lymphocytes with IL-4 intracellular expression and IL-4 concentration in the plasma of patients with idiopathic dilated cardiomyopathy depending on the occurrence of Epstein-Barr virus DNA in PBM cells Different clinical profile of patients with heart failure with reduced ejection fraction with low hepcidin versus higly soluble transferrin receptor in serum Fibrosis of extracellular matrix is inversely related with left ventricular volumes in dilated cardiomyopathy High-sensitive cardiac troponin I in diagnosis of early myocardial damage in patients with acute heart failure Assesment of percentage of T and B lymphocytes with superficial expression of PD-1 molecule in patients with idiopathic dilated cardiomyopathy Chronic heart failure induces changes in the serum blood profile of lipids containing choline – results of the validation study The correlation between soluble ST2 and inflammatory parameters in patients with stable chronic heart failure Alterations of plasma macrophage migration inhibitory factor (MIF) concentration in patients with chronic heart failure treated with cardiac resynchronization therapy Increased levels of urinary biomarkers of tubular injury as a predictor of poor diuretic response in acute heart failure Early changes of biochemical markers of heart failure and myocardial injury after electrical cardioversion of atrial fibrillation Prevention of cardiovascular diseases: risk factors Prevention of cardiovascular diseases: risk factorsModerator: R. Topór-Mądry (Kraków) Ten-year changes in risk SCORE in Polish population resulting from WOBASZ surveys analysis Psychosocial risk factors of cardiovascular diseases in adult Polish population. What changed during last 10 years? – results of two national surveys: WOBASZ and WOBASZ II Smoking habit in Polish population. Results of WOBASZ II survey Trends in the incidence and 12-month mortality in patients hospitalized for cardiovascular diseases in 2006‒2014. Silesian Cardiovascular Database The quality of diet of the adult Polish population – WOBASZ II project Does the place of residence determine the amount of food products important to the prevention of cardiovascular disease consumed? Results of the WOBASZ II Project |
| 12:45 - 14:15 |
Combined therapy for treatment of dyslipidemia in new ESC guidelines Combined therapy for treatment of dyslipidemia in new ESC guidelinesSatellite session organized by MSDChairpersons: A. Gitt (Ludwigshafen) Why do we need combined therapy? Combined therapy – what is new in 2016 ESC guidelines? Practical application of combined therapy |
Cardiology of 21st: more expensive or cheaper? Experts debate Cardiology of 21st: more expensive or cheaper? Experts debateSatellite session organized by AbbottChairpersons: P. Hoffman (Warszawa) Opening Interventional cardiology – how medical technologies improve long-term prognosis for patients? Modern clinical diagnosis in ACS Clinical effectiveness & cost-effectiveness of modern technologies – a key element in selection of therapy? Experts debate Take home message |
Women, wine and signing – opportunities and challenges in contemporary cardiology Women, wine and signing – opportunities and challenges in contemporary cardiologySatellite session organized by KRKAChairpersons: K. Filipiak (Warszawa) Cardioprotection in practice – pharmacological and non-pharmacological What do women want and what they need – in the eyes of cardiologist Music soothes the savage breast – but does it also work on cardiovascular system? |
Essentials for the practitioner of 21st century Essentials for the practitioner of 21st centurySatellite session organized by ServierChairpersons: W. Banasiak (Wrocław) Myocardial infarction, revascularization and what’s next…? ESC HF 2016 Guidelines – what’s new for the practitioners A patient from my practice – when guidelines meet practice Discussion panel with all the lecturers |
New Era of AnticoagulationSatellite session organized by Boehringer-IngelheimChairpersons: P. Mitkowski (Poznań) Are all NOACs the same? New possibilities of anticoagulation reversal Experts’ panel discussion |
|||||||||
| 14:30 - 16:00 |
Coronary disease – progress through the imaging Coronary disease – progress through the imagingSatellite session organized by SIEMENSChairpersons: M. Dziuk (Warszawa) Echocardiography Nuclear cardiology Computed tomography Magnetic resonance Angiography |
Novelty in pharmacological treatment of high-risk cardiovascular patients Novelty in pharmacological treatment of high-risk cardiovascular patientsSatellite session organized by AstraZenecaChairpersons: D. Dudek (Kraków) Why do we have to use antiplatelet therapy for 12 months after an acute coronary syndrome? – latest scientific evidence Innovative diabetes treatments – variety of benefits for every patients with type 2 diabetes |
ARNI in chronic systolic heart failure – compendium of practitioner physician ARNI in chronic systolic heart failure – compendium of practitioner physicianSatellite session organized by NovartisChairpersons: J. Nessler (Kraków) Improving the prognosis of patients with chronic systolic heart failure – PARADIGM-HF research result Practical aspects of dosing ARNI to patient with HFrEF Safety of sacubitrilum/valsartan pharmacotherapy in clinical practice |
"Better to ask the way than go astray" – series of frequently asked questions in the area of hypercholesterolemia, hypertension, heart failure and pain treatmentSatellite session organized by SandozChairpersons: A. Mamcarz (Warszawa) Wykładowcy |
Ancient philosophy and contemporary cardiology: one can never step in the same river twice Ancient philosophy and contemporary cardiology: one can never step in the same river twiceSatellite session organized by Berlin-Chemie MenariniChairpersons: K. Filipiak (Warszawa) Introduction When, in optimal manner, the antihypertensive therapy should be started, and with which drug? When, in optimal manner, the cardioprotective treatment in patient with CAD should be started, and with which drug? When, in optimal manner, the cardioprotective treatment in patient with HF should be started, and with which drug? Summary |
Oral anticoagulation considering the new ESC Atrial Fibrillation Guidelines 2016 Oral anticoagulation considering the new ESC Atrial Fibrillation Guidelines 2016Satellite session organized by PfizerChairpersons: A. Budaj (Warszawa) Cardiologist’s perspective Coagulation expert’s perspective Neurologist’s perspective Wrap-up and discussion Adherence in cardiology New adherence-supporting technologies |
||||||||
| 16:30 - 18:00 |
Update on heart valvesFrench-German-Polish sessionChairpersons: A. Vahanian (Paryż) Does MitraClip affect mortality in patients with secondary MR? Percutaneous annuloplasty in patients with secondary MR TAVR vs. SAVR in patients with aortic stenosis and moderate risks |
Athlete's heart – adaptation or also pathology? Athlete's heart – adaptation or also pathology?Chairpersons: W. Braksator (Warszawa) ECG, athlete's heart – interpretation of current guidelines Athlete's heart, arrhythmia is more common, especially atrial fibrillation – facts and myths Does a marathon harm the heart? Impact of strength and extreme effort on the heart The role of genetics in sport – who can run sprint, who can run a marathon, and who's out? |
Echo stress – additional helpful tool for decision-making Echo stress – additional helpful tool for decision-makingChairpersons: M. Kowalski (Warszawa) Patient with dyspnea in diabetes Patient with asymptomatic severe heart failure Patient with simulator and discomfort in the chest Patient with symptoms but unconfirmed heart failure |
Difficult cases of heart defects. What did they teach us – continuum Difficult cases of heart defects. What did they teach us – continuumChairpersons: G. Brzezińska-Rajszys (Warszawa) Waiting for the heart – long-term support of ECMO as a bridge to transplant – a challenge for the Heart Team Palliative treatment of patient with cyanotic congenital heart disease – have we reached a therapeutic dead end? Coronary arteries fistulas – interventions or surgeries? |
Guidelines in electrophysiology and electrotherapy Guidelines in electrophysiology and electrotherapySession recommended by Scientific Committee for PCS CongressesChairpersons: P. Mitkowski (Poznań) ICD therapy CRT therapy Lead-dependent endocarditis ICD – programming and testing |
Repolarization – the ECG trash or how to see important abnormalities Repolarization – the ECG trash or how to see important abnormalitiesChairpersons: R. Ochotny (Poznań) Normal repolarization pattern and non-cardiac factors affecting the repolarization pattern Genetically determined repolarization abnormalities Secondary repolarization abnormalities caused by cardiac factors How to recognise features of ischaemia correctly? |
Advances in the treatment of myocardial infarction complicated by cardiogenic shock Advances in the treatment of myocardial infarction complicated by cardiogenic shockThe joint session of the PCS Working Group on Cardiac Intensive Care and Resuscitation and the PCS Association Group on Cardiovascular InterventionsChairpersons: B. Sobkowicz (Białystok) Myocardial revascularization Mechanical circulatory support (IABP, LVAD, ECMO) Therapeutic hypothermia after sudden cardiac arrest Intensive cardiac care Cardiac surgery treatment Treatment of the myocardial infarction complicated by cardiogenic shock in Poland |
Advanced heart failure – what can be done better? Advanced heart failure – what can be done better?Session recommended by the Scientific Committee for PCS CongressesChairpersons: P. Ponikowski (Wrocław) Congestion and euvolemia Organ hypoperfusion Ventricular arrhythmia Which patient should be considered for mechanical circulatory support and heart transplantation? |
The role of a cardiologist in the treatment of atherosclerosis The role of a cardiologist in the treatment of atherosclerosisChairpersons: A. Witkowski (Warszawa) Prevention of vascular diseases according to guidelines of scientific associations for patients with multilevel atherosclerosis Intermittent claudication and atherosclerosis of lower extremities - prognosis for patients with multilevel atherosclerosis Prognosis for patients with critical limb ischaemia – possible therapeutic perspectives Atherosclerotic occlusive of the aortic arch and the treatment of coronary heart disease – dilemmas of a cardiologist and a cardiac surgeon Interventions in the area of renal arteries as a therapeutic option for advanced heart diseases – new therapeutic opportunities Panel discussion: the role of a cardiologist in specialised teams dealing with prevention and treatment of vascular diseases |
Prognostic factors in congestive heart failure Prognostic factors in congestive heart failureChairpersons: E. Straburzyńska-Migaj (Poznań) The impact of severe mitral insufficiency on outcome and treatment qualification in systolic heart failure patients Long-term prognosis in population of Polish patients with heart failure and atrial fibrillation in the European Society of Cardiology heart failure long-term registry Impact of a chronic total occlusion of the coronary artery on long-term prognosis in patients with ischemic systolic heart failure – insights from contemporary modalities In treatment of heart failure (COMMIT-HF) registry Abnormal erythropoietin level in anaemic patients with heart failure is related to disease severity and renal impairment, but do not correlate neither with inflammation nor with iron deficiency Summary – prognostic factors in a congestive heart failure |
Cardiac injury in complications of influenza. Prevention or therapy? Cardiac injury in complications of influenza. Prevention or therapy?The session of Polish National Programe for Influenza PreventionChairpersons: A. Antczak (Łódź) Cardiovascular complications of influenza. Presentation of clinical cases Influenza as a factor initiating acute coronary syndrome (ACS) Current indications in application of influenza prevention among cardiac patients Can we expect vaccines against hypertension and arthrosclerosis in the future? |
What is new in treatment and diagnostics of patients with congenital cardiac defect What is new in treatment and diagnostics of patients with congenital cardiac defectChairpersons: L. Tomkiewicz-Pająk (Kraków) Hypokalemia in adults with atrial septal defect – prevalence and relation to arrhythmia Late gadolinium enhancement and exercise capacity in adults with Ebstein's anomaly Investigating the purview of Melody valve implantation for the pediatric population – an alluring option Early experience with novel three-dimensional image fusion software for guidance of complex cardiac catheterizations in patients with congenital heart defects Summary – what is new in diagnostics and treatment of patients with congenital cardiac defects |
Heart failure as a cardiogeriatric syndrome Heart failure as a cardiogeriatric syndromeChairpersons: K. Josiak (Wrocław) Comprehensive assessment of an elderly patient with heart failure Therapy of co-morbidities in an elderly patient with heart failure Specific features of pharmacotherapy of an elderly patient with heart failure |
Cardiac surgeryModerator: M. Krejca (Katowice) The impact of infection on long term outcomes in patients with a continuous-flow left ventricular assist device (CF-LVAD) – Zabrze experience The comparison of hepatic dysfunction based on MELD-XI score in patients underwent bicaval and biatrial techniques for heart transplant. One-year observation Pitfalls in frailty assessment in cardiac surgery-comparison of two diagnostic tools Value of prognostic geriatric’s scale in estimate of risk of complications in patients ≥70 years of age after cardiosurgery treatment The assessment of complications in patients ≥75 years of age underwent cardiac surgeries in the centre in Zabrze over the period 2010‒2012 First in human safety study of micronized extracellular matrix implantation in post-infarction ischemic heart failure Early and late clinical outcomes of patients with heavily calcified coronary artery lesions treated with coronary artery bypass grafting Does the abnormal level of HbA1c or fructosamine have influance on postsurgical complcations after CABG in diabetic patients? Red blood cell count as a prognostic marker in patients undergoing heart valve surgery The comparison of totally thoracoscopic transareolar mitral and tricuspid valve repair and right-sided minithoracotomy Cardiac and vascular imagingModerator: T. Kukulski (Zabrze) Cardiovascular dysfunction in patients with systemic sclerosis 3-dimensional over 2-dimensional transesophageal echocardiography in selection of occluders for percutaneous left atrial closure Hemodynamic indices of the left atrium as predictors of maintenance of sinus rhythm after cardioversion for persistent non-valvular atrial fibrillation – a prospective study Baseline renal resistive index accurately predicts contrast-induced acute kidney injury after coronary angiography in patients with coronary artery disease and initially preserved renal function Analysis of the significance of ultrasonographic renal blood flow parameters for the prediction of contrast-induced acute kidney injury after coronary angiography Impact of carotid artery revascularization on the cognitive and functional outcome, as well as cerebral flow on TCD and brain MRI in patients with symptomatic carotid artery stenosis: a preliminary report Tomographic predictors of side branch compromise after percutaneous coronary intervention in bifurcation lesions Pocket-size imaging devices in the initial assessment of patients with suspected pulmonary embolism Higher values of left ventricular apical rotation and twist in patients with severe aortic valve stenosis compared with controls SYNTAX and GENSINI score correlation with left ventricular global systolic strain at rest and during peak stage of dobutamine stress echocardiography (DSE) Cognitive and clinical value of the hemodynamic assessment by impedance cardiography in Cushing's disease Exercise echocardiography in patients with exercise intolerance and lower intermediate pretest probability of coronary artery disease Prevention of cardiovascular diseases: prognostic factors Prevention of cardiovascular diseases: prognostic factorsModerator: D. Szalewska (Gdańsk) Every second patient with cardiac resynchronization device-related infective endocarditis does not leave hospital alive – what are the mortality predictors of this life-threatening condition? The relationship between walking abilities, endothelial function and prostanoids release in patients with peripheral artery disease (PAD) undergoing supervised training treadmill program (STTP) Blood pressure in relation to 24-hour urinary sodium excretion and renal sodium handling How the risk of cardiovascular death depends on the socioeconomic status? Relationship between concentrations of vasopressin and natriuretic peptydes as a prognostic factor of patients after cardiac arrest Does the presence of selected modifiable risk factors increase the chance for the awareness of their contribution to the pathogenesis of coronary heart disease and erectile dysfunction in a group of patients with CHD and ED? Improvement of left ventricular function after percutaneous coronary intervention in patients with stable coronary artery disease and preserved ejection fraction Carotid intima-media thickness as an early marker of atherosclerosis and brachial artery flow mediated dilatation-endothelial function in patients with mild and moderate psoriasis Factors determinig exercise capacity evaluated during cardiopulmonary exercise testing in 6-month follow up after ST elevation myocardial infarction |
| 18:15 - 18:55 |
Meeting of Reviewers, Scientific Board and Board of Editors of the „Polish Heart Journal” Meeting of Reviewers, Scientific Board and Board of Editors of the „Polish Heart Journal”Awarding statuettes for the most frequently citing and cited authorsChairpersons: K. Filipiak (Warszawa) |
|||||||||||||
Saturday17September |
SALA 1 | SALA 2 | SALA 3 | SALA 4 | SALA 5 | SALA 6 | SALA 7 | SALA 8 | SALA 9 | SALA 10 | SALA 11 | SALA 12 | SALA 13 | SALA Sesje plakatowe |
| 09:00 - 10:30 |
Acute failure of the right ventricle Acute failure of the right ventricleChairpersons: J. Stępińska (Warszawa) High risk acute pulmonary embolism Advanced pulmonary hypertension Right ventricular myocardial infarction Acute right ventricular failure in cardiac surgery and heart transplantation |
Management optimalization in STEMI Management optimalization in STEMIChairpersons: J. Kubica (Bydgoszcz) Complete revascularization is an optimal intervention in STEMI Dual antiplatelet therapy in STEMI should be initiated as early as possible |
Bioresorbable scaffolds for complex coronary lesions Bioresorbable scaffolds for complex coronary lesionsChairpersons: Ł. Rzeszutko (Kraków) Chronic total occlusion CTO Coronary artery bifurcations Calcified lesions Acute coronary syndrome In-stent restenosis |
My patient with an implanted device My patient with an implanted deviceChairpersons: P. Mitkowski (Poznań) Has indications for MRI Has indications for oncological radiotherapy Wants to return to work Wants to do sport |
Algorithms for acute heart failure Algorithms for acute heart failureChairpersons: T. Rywik (Warszawa) How to carry out initial assessment of a patient with ONS in a hospital emergency ward? Who can be discharged? How to plan up further care? Who needs to be admitted to an intensive cardiac care unit? How to plan up further care before discharging from a hospital? |
Resistant hypertension – how to diagnose, how to treat? Resistant hypertension – how to diagnose, how to treat?Chairpersons: A. Tykarski (Poznań) Resistant hypertension – clinical importance and diagnostics Optimal combination drug therapy – how to fight with resistance of hypertension? Therapeutic compliance – are all patients indeed resistant? Interventional treatment of resistant hypertension – in which patients is effective? |
Patient with heart failure – difficult scenarios, difficult decisions Patient with heart failure – difficult scenarios, difficult decisionsChairpersons: E. Płońska-Gościniak (Szczecin) Patient with heart failure and diabetes Patient with heart failure and atrial fibrillation Patient with severe heart failure and kidney failure |
How to stay healthy and look young? How to stay healthy and look young?Session under the patronage of the Polish Forum for Prevention of Cardiovascular DiseasesChairpersons: P. Podolec (Kraków) Use appropriate stimulants Practice proper physical activity Eating with awareness Discussion with the experts and the press |
The heart and the environmentChairpersons: M. Kurpesa (Łódź) The impact of air pollution on the cardiovascular system The noise as a cardiological risk factor The influence of modern technologies on the cardiovascular system Does the heart like shift work? |
Interventional treatment of congenital cardiac defects in adults – new future prospects Interventional treatment of congenital cardiac defects in adults – new future prospectsChairpersons: G. Brzezińska-Rajszys (Warszawa) Transcatheter tricuspid valve-in-valve implantation into a failing surgical bioprosthesis in a high-risk patient Percutaneous closure of an aortopulmonary window using Amplatzer Duct Occluder II: Additional Sizes – the first reported case Percutaneous closure of patent foramen ovale in a patient with Ebstein’s anomaly Pulmonary arterial hypertension in 76-year-old female with huge coronary fistula from LCx to coronary sinus |
The importance of interdisciplinary cooperation in improvement of prognosis in patients with cardiovascular diseasesChairpersons: D. Dudek (Kraków) When to stop cardiovascular interventions in elderly patients? The cardiologist’s point of view When to stop cardiovascular interventions in elderly patients? The geriatrician's point of view When in prevention of cardiac causes of stroke an intervention is more effective than pharmacotherapy? The cardiologist’s point of view When in prevention of cardiac causes of stroke an intervention is more effective than pharmacotherapy? The neurologist’s point of view What should the optimal model of intensive cardiac care look like? The cardiologist’s point of view What should the optimal model of intensive cardiac care look like? The anesthesia and intensive care specialist's point of view |
Comprehensive cardiac surgeries and endovascular procedures in high-risk patients Comprehensive cardiac surgeries and endovascular procedures in high-risk patientsChairpersons: R. Kalawski (Poznań) Aortic valve reconstuction with autologous pericardium in young patient with parathyroid adenoma and severe regurgitation of bicuspid aortic valve Transapical mitral valve in ring implantation after unsuccessful mitral valve repair Carotid artery stenting with the use of proximal neuroprotection device and mesh-covered stent implantation for the treatment of severe, bilateral carotid artery stenosis in a high-risk patient Left ventricle assist device supported rotational atherectomy of the highly calcified last remaining vessel in a patient with acute myocardial infarction and reduced left ventricular function |
Novelties and progress in cardiac surgery Novelties and progress in cardiac surgeryChairpersons: J. Różański (Warszawa) Outcomes of surgical treatment of patients with severe ischemic left ventricular dysfunction (EF ≤35%) Totally thoracoscopic left atrial appendage occlusion using novel epicardial clipping system for stroke prevention in high risk patietns Transapical off-pump mitral valve repair. First experiences with Neochord system in Poland Why I choose minimally invasive aortic valve replacement? Risk-adjusted comparative analysis of 438 cases Hybrid approach of percutaneous coronary intervention and minimally invasive aortic valve replacement surgery Summary – minimally invasive interventions in cardiac surgery |
Treatment aspects of selected cardiac diseases Treatment aspects of selected cardiac diseasesModerator: M. Kmiecicka (Warszawa) Male patients undergo more difficult and more expensive percutaneous coronary procedures despite younger age The determinants of cath lab cost in patients undergoing coronary angioplasty due to acute coronary syndromes Usefulness of the web-based wireless telemonitoring system in patients with the heart failure treated with the resynchronization therapy – preliminary results from one center X-ray dose analysis during angioplasty procedures in consecutive patients with acute coronary syndromes ElectrocardiologyModerator: B. Małecka (Kraków) What is the background of ST depression in AVNRT and AVRT? Series of 25 cases of life-threatening arrhythmic events in Wolff-Parkinson-White syndrome The variability of the his-to-his intervals is asymmetrical Atrioventricular block but not left bundle branch block predicts exercise capacity in patients with heart failure with reduced ejection fraction Do supraventricular arrhythmias influence prognosis in patients with asymptomatic severe aortic stenosis? The influence of class III antiarrhythmic drugs on long-term clinical outcome of electrical storm treatment Heart defects: diagnostics and treatment Heart defects: diagnostics and treatmentModerator: O. Trojnarska (Poznań) Improvement of exercise capacity after transcatheter closure of atrial septal defect is affected by tricuspid insufficiency Red cell distribution width as a prognostic marker in patients undergoing valve surgery The benefits of atrial septal defect closure in the elderly Global longitudinal strain changes during exercise in severe asymptomatic aortic stenosis Severe degenerative AS with preserved ejection fraction does not change adipokine serum levels Exercise tolerance and quality of life of children after arterial switch operation for the transposition of the great arteries Can perimeter of the defect determine occluder size in transcatheter closure of ostium secundum atrial septal defect? Chellanges in severe heart failure Chellanges in severe heart failureModerator: M. Sobieszczańska-Małek (Warszawa) Predictors of early and late deaths in patients with no-ACS severe acute heart failure treated by heart failure team in the hybrid cardiac intensive care / intensive care unit – analysis from NYHA IV+ registry The overhydration as an atypical effect independent from diuretics treatment in patients with dilated cardiomyopathy Prognostic significance of multi-organ dysfunction/damage in acute heart failure The influence of ventilatory disorders on the early and late prognosis in patients with chronic heart failure exacerbation Clinical characteristics, treatment and outcomes of patients with ischemic and non-ischemic etiology of severe acute heart failure (NYHA IV+ registry) Prognostic value of (R)CHADS2 and (R)CHA2DS2-VASc scores in patients with acute heart failure in sinus rhythm – results from the Polish part of the ESC-HF Pilot Survey Comparison of results after left ventricular assist device implantation in patients with optimal and borderline echocardiographic assessment of right ventricle function Predictors of severe mitral regurgitation improvement after 6 months of cardiac resynchronization therapy Device-related infective endocarditis in cardiac resynchronization therapy recipients – single center registry with over 2500 person-years follow up Heart failure team in real-life conditions – a group effort to optimize treatment of the most complex heart failure patient subpopulation Reverse remodeling of the left ventricle as a sign of regression of uremic cardiomyopathy in patients after renal transplantation – long-term follow-up |
| 11:00 - 12:30 |
The most frequent problems in patients with implanted devices The most frequent problems in patients with implanted devicesChairpersons: A. Kutarski (Lublin) My patient after implantation of the device is pyrexial My patient after implantation of the device faints My patient after implantation of the device has palpitation My patient after implantation of the device is awaiting surgical procedure |
Cardiac surgeon or cardiologist? Cardiac surgeon or cardiologist?Session under the patronage of the Centre for Rare Cardiovascular Diseases in KrakowChairpersons: P. Podolec (Kraków) Endocarditis on reoperated aortic valve – a case and cardiologist's point of view Endocarditis on reoperated aortic valve – cardiac surgeon's point of view Arrhytmias in an adult patient with single ventricle – a case and cardiologist's point of view Arrhytmias in an adult patient with single ventricle – cardiac surgeon's point of view Patient with chronic thromboembolic pulmonary hypertension – a case and cardiologist's point of view Patient with chronic thromboembolic pulmonary hypertension – cardiac surgeon's point of view |
Functional mitral regurgitation – diagnosis and treatment options Functional mitral regurgitation – diagnosis and treatment optionsChairpersons: E. Straburzyńska-Migaj (Poznań) Functional mitral regurgitation – echo assessment and prognosis Functional mitral regurgitation – surgical treatment Functional mitral regurgitation – percutaneous techniques |
Old and new markers of cardiovascular disease. Is it worth to use them in everyday clinical practice?Chairpersons: P. Jankowski (Kraków) Central blood pressure and pulse wave velocity Calcium score IMT and other ultrasound techniques CRP, uric acid, lipoprotein (a) and other soluble markers |
Cardiology and pregnancy – the difficult art of interdisciplinary care of a mother and her baby Cardiology and pregnancy – the difficult art of interdisciplinary care of a mother and her babyChairpersons: M. Demkow (Warszawa) Heart failure In pregnancy Cardiac arrythmias In pregnancy Obstetric care in pregnant women with cardiac problems USG and echocardiography in fetuses of women with cardiac problems |
Integrated cardiac care after myocardial infarction – it is high time to start making joint decisionsChairpersons: G. Opolski (Warszawa) Risk stratification after acute phase – significance of the personalised approach Antiplatelet treatment – how long and is it similar in all patients Revascularisation in acute coronary disease – how and when to qualify to a surgical procedure Implantable cardioverter-defibrillator – when and whether in all patients with reduction in the ejection fraction of the left ventricle Cardiac rehabilitation following myocardial infarction – not for everyone? The status of interventional cardiology centres and ambulatory care in the model of the integrated health care system |
Atrial fibrillation Anno Domini 2016 Atrial fibrillation Anno Domini 2016Chairpersons: T. Mularek-Kubzdela (Poznań) Guidelines for anticoagulation in a patient with atrial fibrillation Anno Domini 2016 Position of ablation in the treatment of patients with atrial fibrillation – whom refer to such treatment? When does my patient with atrial fibrillation requires the implantation of a pacemaker CRT-D/CRT-P/ICD? In which patient should we consider left atrial appendage closure? |
Best from ESC 2016 in RomeSession of the „Club 30”Chairpersons: P. Burchardt (Poznań) Coronary heart disease Non-invasive imaging techniques Heart failure and cardiomyopathies Electrotherapy Pulmonary hypertension Preventive cardiology and hypertension Intensive cardiac care |
Transcatheter aortic valve implantation (TAVI): where are we now? where are we going? Transcatheter aortic valve implantation (TAVI): where are we now? where are we going?Chairpersons: M. Jasiński (Katowice) TAVI: changing paradigm in the years 2002–2016 as a result of randomized trials, registries and daily clinical practice TAVI and paravalvular leaks: did second-generation valves already solve this problem? How to avoid serious complications in TAVI? Who is a candidate for surgical approach in TAVI? Are we ready to perform TAVI procedures in intermediate and low surgical risk patients? |
Imaging of selected cardiac muscle pathologies Imaging of selected cardiac muscle pathologiesChairpersons: T. Miszalski-Jamka (Kraków, Wrocław) Viral myocarditis in patients with suspected acute coronary syndrome – the diagnostic value of cardiac magnetic resonance In the search of new diagnostic criteria of left ventricular noncompaction Antracyclin-based chemotherapy and echocardiographic indices in patients with non-Hodgkin’s lymphoma The usefulness of echocardiography in diagnosing subclinical systolic and diastolic left ventricular dysfunction in Cushing's disease Cardiac magnetic resonance in patient with eosynophilic myocarditis Summary – rare cardiac muscle diseases – the imaging techniques I use |
Challenging and atypical patients Challenging and atypical patientsChairpersons: L. Bryniarski (Kraków) A 19-year-old male patient with anterior wall STEMI, thrombocytosis and homocysteine transformations gene polymorphism Double thrombolysis in the early pregnancy can be safe Staged percutaneous coronary intervention as a treatment of three-vessel coronary disease with left main coronary disease in a patient with congenital glucose-6-phosphate dehydrogenase deficiency Prosthetic valve endocarditis after transcatheter CoreValve Evolut R bioprosthesis implantantion |
Difficult questions – ambiguous answers? Difficult questions – ambiguous answers?Chairpersons: M. Wolszczak (Warszawa) Older female patients undergoing coronary angioplasty from radial approach require higher X-ray doses Care for patients with implantable VAD Influence of vasovagal syncope on car driving and traffic safety |
Renovascular hypertension – new studies, new data Renovascular hypertension – new studies, new dataChairpersons: A. Januszewicz (Warszawa) Atherosclerotic renal artery stenosis – management after CORAL study Fibromuscular dysplasia – related not only to renal arteries Other, unappreciated causes of renovascular hypertension Management of renovascular hypertension – clinical cases |
|
| Working Group Session |
| Session of clinical cases |
| Original papers session - oral presentations |
| Original papers session - moderated posters |
| Special Session |
| Satellite Session |
| Educational Session |
Dear Sirs,
The XX International Congress of the Polish Cardiac Society is ahead of us. There have been implemented a lot of changes, also in the organizing process, since the I International Congress of the Polish Cardiac Society on September 4-6, 1997 took place. The abstract system, e-mails, mobile applications, online registration have gradually displaced paper registration forms, paper acknowledgements of receipt of an abstract as well as announcements and preliminary information in writing. Moreover, our conference rooms are more and more modern.
However, the main purpose of the meeting has remained unchanged for many years since power of our meetings lies within our excellent scientific program, exceptional people and an impressive attendance. The program and people have stood behind our success for twenty years.
We invite you to a sentimental journey. We present a unique gallery of participants and our scientific programs. Unfortunately, not all of them have been already found. In some cases, the cover of the program is replaced with printed announcements and information. Hence, we kindly ask you to send your conference keepsakes, missing covers, photos with brief notes about their content. We will create a wonderful gallery.
Please, send the pictures on: ptk2016@casusmedical.pl
Programs
 |
 |
 |
 |
|||
 |
 |
 |
 |
|||
 |
 |
 |
 |
|||
 |
 |
 |
 |
|||
 |
 |
People
Just before the I International Congress of the Polish Cardiac Society...
55. Kongres PTK, 15-17.09.1994 r., Poznań |
57. Kongres PTK, 31.08-1.09.1995 r. Warszawa  |
VI Międzynarodowy Kongres PTK, 19-21.09.2002 r., Poznań
 |
 |
 |
VIII Międzynarodowy Kongres PTK, 15-18.09.2004 r., Warszawa
 |
 |
 |
 |
 |
 |
XV Międzynarodowy Kongres PTK, 6-8.10.2011 r., Wrocław
 |
 |
 |
 |
 |
 |
XVI Międzynarodowy Kongres PTK, 20-22.09.2012 r., Poznań
 |
 |
 |
 |
 |
 |
XVII Międzynarodowy Kongres PTK, 26-28.09.2013 r., Wrocław
 |
 |
 |
 |
 |
 |
Główny Sponsor Kongresu
Sponsorzy Kongresu
Sesje Satelitarne Kongresu
Patronat Medialny
Wsparcie Organizacyjne
